Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 13, 2026
Total Value: $1.755B (97.9% shares, 2.1% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 1,500,000 | $183M | 10.4% | — | — | Put | 78464A870 |
| APGE | APOGEE THERAPEUTICS INC | 1,234,926 | $93.21M | 5.3% | $38.88 | +62.0% | COM | 03770N101 |
| INSM | INSMED INC | 450,000 | $78.32M | 4.5% | $72.50 | +151.7% | COM PAR $.01 | 457669307 |
| ABVX | ABIVAX SA | 505,000 | $68.1M | 3.9% | $83.67 | — | SPONSORED ADS | 00370M103 |
| IBB | ISHARES TR | 400,000 | $67.51M | 3.8% | — | — | Call | 464287556 |
| VTYX | VENTYX BIOSCIENCES INC | 6,484,558 | $58.56M | 3.3% | $3.93 | +90.3% | COM | 92332V107 |
| XENE | XENON PHARMACEUTICALS INC | 1,250,000 | $56.02M | 3.2% | $39.23 | +7.1% | COM | 98420N105 |
| PRAX | PRAXIS PRECISION MEDICINES I | 185,000 | $54.53M | 3.1% | $186.22 | 0.0% | COM NEW | 74006W207 |
| CYTK | CYTOKINETICS INC | 800,000 | $50.83M | 2.9% | $53.01 | +17.3% | COM NEW | 23282W605 |
| SYRE | SPYRE THERAPEUTICS INC | 1,432,591 | $46.93M | 2.7% | $18.18 | +43.7% | COM NEW | 00773J202 |
| WVE | WAVE LIFE SCIENCES LTD | 2,700,000 | $45.9M | 2.6% | $7.78 | +30.5% | SHS | Y95308105 |
| AMGN | AMGEN INC | 135,000 | $44.19M | 2.5% | $315.95 | 0.0% | Call | 031162100 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,400,000 | $43.69M | 2.5% | $8.35 | — | SPONSORED ADS | 881624209 |
| XLV | SELECT SECTOR SPDR TR | 250,000 | $38.7M | 2.2% | — | — | Call | 81369Y209 |
| ROIV | ROIVANT SCIENCES LTD | 1,700,000 | $36.89M | 2.1% | $15.91 | +24.0% | SHS | G76279101 |
| ACLX | ARCELLX INC | 523,725 | $34.15M | 1.9% | $46.50 | +71.6% | COMMON STOCK | 03940C100 |
| NUVL | NUVALENT INC | 322,633 | $32.45M | 1.8% | $72.88 | +35.3% | COM | 670703107 |
| LXEO | LEXEO THERAPEUTICS INC | 3,200,000 | $31.78M | 1.8% | $3.84 | +137.8% | COM | 52886X107 |
| ALKS | ALKERMES PLC | 1,000,000 | $27.98M | 1.6% | $26.24 | +14.1% | SHS | G01767105 |
| FBRX | FORTE BIOSCIENCES INC | 989,490 | $26.98M | 1.5% | $17.53 | 0.0% | COM NEW | 34962G208 |
| TRVI | TREVI THERAPEUTICS INC | 2,150,172 | $26.92M | 1.5% | $5.69 | +102.9% | COM | 89532M101 |
| MLYS | MINERALYS THERAPEUTICS INC | 730,000 | $26.49M | 1.5% | $11.77 | +240.8% | COM | 603170101 |
| BBIO | BRIDGEBIO PHARMA INC | 320,000 | $24.48M | 1.4% | $58.10 | +13.0% | COM | 10806X102 |
| ORKA | ORUKA THERAPEUTICS INC | 802,342 | $24.32M | 1.4% | $21.60 | +29.0% | COM | 687604108 |
| TERN | TERNS PHARMACEUTICALS INC | 550,000 | $22.22M | 1.3% | $23.11 | 0.0% | COM | 880881107 |
| ANAB | ANAPTYSBIO INC | 444,692 | $21.56M | 1.2% | $38.98 | 0.0% | COM | 032724106 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,932,106 | $20M | 1.1% | $9.03 | -0.1% | COM | 230031106 |
| — | OMEROS CORP | 6,525,000 | $19.38M | 1.1% | $1.12 | — | NOTE 9.500% 6/1 | 682143AK8 |
| QURE | UNIQURE NV | 800,000 | $19.14M | 1.1% | $16.30 | +136.8% | Call | N90064101 |
| AVTX | AVALO THERAPEUTICS INC | 1,051,054 | $19.09M | 1.1% | $9.90 | +70.6% | COM NEW | 05338F306 |
| NRIX | NURIX THERAPEUTICS INC | 967,620 | $18.36M | 1.0% | $10.44 | +37.6% | COM | 67080M103 |
| TSHA | TAYSHA GENE THERAPIES INC | 3,300,000 | $18.15M | 1.0% | $2.98 | +63.2% | COM SHS | 877619106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 31,131 | $18.13M | 1.0% | $216.49 | +135.9% | COM | 558868105 |
| SVRA | SAVARA INC | 2,797,153 | $16.87M | 1.0% | $3.81 | +28.4% | COM | 805111101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 172,125 | $15.03M | 0.9% | $81.85 | 0.0% | COM | 74366E102 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 600,552 | $15.02M | 0.9% | $12.11 | — | SPONSORED ADS | 152309100 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 200,000 | $14.58M | 0.8% | $53.71 | +12.4% | COM | G31249108 |
| ERAS | ERASCA INC | 3,900,000 | $14.51M | 0.8% | $1.90 | +47.9% | COM | 29479A108 |
| VERA | VERA THERAPEUTICS INC | 250,000 | $12.66M | 0.7% | $31.26 | +13.6% | CL A | 92337R101 |
| COGT | COGENT BIOSCIENCES INC | 350,000 | $12.43M | 0.7% | $28.11 | 0.0% | COM | 19240Q201 |
| OVID | OVID THERAPEUTICS INC | 7,150,000 | $11.65M | 0.7% | $1.27 | +21.6% | COM | 690469101 |
| TVTX | TRAVERE THERAPEUTICS INC | 300,000 | $11.46M | 0.7% | $19.81 | +64.2% | COM | 89422G107 |
| JBIO | JADE BIOSCIENCES INC | 714,956 | $11.03M | 0.6% | $13.70 | -14.4% | COM NEW | 008064206 |
| — | TRAVERE THERAPEUTICS INC | 7,000,000 | $9.989M | 0.6% | $0.90 | — | NOTE 2.250% 3/0 | 89422GAA5 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 275,000 | $9.647M | 0.5% | $17.93 | +103.0% | ORDINARY SHARES | N62509109 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 350,000 | $9.506M | 0.5% | $23.62 | +11.5% | COM NEW | 15117B202 |
| ZURA | ZURA BIO LTD | 1,813,671 | $9.504M | 0.5% | $2.65 | +49.0% | CLASS A ORD SHS | G9TY5A101 |
| TNGX | TANGO THERAPEUTICS INC | 1,000,000 | $8.86M | 0.5% | $8.62 | 0.0% | COM | 87583X109 |
| STRO | SUTRO BIOPHARMA INC | 748,382 | $8.659M | 0.5% | $9.49 | 0.0% | COM SHS | 869367201 |
| RVMD | REVOLUTION MEDICINES INC | 100,000 | $7.965M | 0.5% | $39.15 | +67.5% | COM | 76155X100 |
| MBX | MBX BIOSCIENCES INC | 250,000 | $7.885M | 0.4% | $17.07 | +42.1% | COM | 55287L101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 250,000 | $7.78M | 0.4% | $16.46 | +66.6% | COM | 92790C104 |
| RCUS | ARCUS BIOSCIENCES INC | 300,000 | $7.149M | 0.4% | $20.40 | 0.0% | COM | 03969F109 |
| SGMT | SAGIMET BIOSCIENCES INC | 1,148,245 | $6.798M | 0.4% | $7.47 | -3.8% | COM SER A | 786700104 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 889,575 | $6.547M | 0.4% | $6.12 | 0.0% | COM NEW | 48576U205 |
| — | CELCUITY INC | 3,000,000 | $6.516M | 0.4% | $1.33 | — | NOTE 2.750% 8/0 | 15102KAA8 |
| ASND | ASCENDIS PHARMA A/S | 30,000 | $6.397M | 0.4% | $213.24 | — | SPONSORED ADR | 04351P101 |
| SMMT | SUMMIT THERAPEUTICS INC | 350,000 | $6.122M | 0.3% | — | — | Put | 86627T108 |
| VRCA | VERRICA PHARMACEUTICALS INC | 707,338 | $5.878M | 0.3% | $5.54 | 0.0% | COM SHS | 92511W207 |
| ENGN | ENGENE HOLDINGS INC | 643,370 | $5.81M | 0.3% | $7.50 | +6.8% | COM | 29286M105 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 245,000 | $5.635M | 0.3% | $6.02 | — | *W EXP 99/99/999 | N62509117 |
| RZLT | REZOLUTE INC | 2,351,144 | $5.549M | 0.3% | $2.90 | +170.7% | COM NEW | 76200L309 |
| — | AVADEL PHARMACEUTICALS PLC | 250,000 | $5.388M | 0.3% | $21.55 | — | COM SHS | G29687103 |
| CLYM | CLIMB BIO INC | 1,300,000 | $5.2M | 0.3% | $3.30 | -27.2% | COM | 28658R106 |
| IMVT | IMMUNOVANT INC | 200,000 | $5.084M | 0.3% | $16.19 | +37.7% | COM | 45258J102 |
| PRQR | PROQR THRAPEUTICS N V | 2,454,278 | $4.958M | 0.3% | $2.92 | -20.0% | SHS EURO | N71542109 |
| DNTH | DIANTHUS THERAPEUTICS INC | 115,000 | $4.739M | 0.3% | $25.56 | +51.7% | COM | 252828108 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 70,000 | $4.647M | 0.3% | $49.01 | 0.0% | COM | 04280A100 |
| IBIO | IBIO INC | 2,057,200 | $3.97M | 0.2% | $1.36 | 0.0% | COM NEW | 451033708 |
| NXTC | NEXTCURE INC | 247,294 | $3.509M | 0.2% | $6.38 | +62.4% | COM NEW | 65343E207 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 75,000 | $3.491M | 0.2% | $27.88 | +59.7% | COM | 22663K107 |
| AMGN | AMGEN INC | 10,000 | $3.273M | 0.2% | $315.95 | 0.0% | COM | 031162100 |
| BLTE | BELITE BIO INC | 20,000 | $3.199M | 0.2% | $159.96 | — | SPONSORED ADS | 07782B104 |
| AVBP | ARRIVENT BIOPHARMA INC | 150,000 | $3.018M | 0.2% | $20.82 | 0.0% | COM | 04272N102 |
| — | MERSANA THERAPEUTICS INC | 100,000 | $2.893M | 0.2% | $28.93 | — | COM | 59045L205 |
| OACCU | OAKTREE ACQUISITION CORP III | 250,000 | $2.652M | 0.2% | $10.15 | — | UNIT 10/04/2029 | G6717R120 |
| ABUS | ARBUTUS BIOPHARMA CORP | 521,900 | $2.51M | 0.1% | — | — | Call | 03879J100 |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 486,684 | $2.429M | 0.1% | $5.48 | -16.3% | COM | 03675P102 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 572,804 | $2.377M | 0.1% | $2.76 | +46.2% | COM | 68572M106 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 300,000 | $2.265M | 0.1% | $5.44 | +13.3% | COM | 29842P105 |
| GERN | GERON CORP | 1,500,000 | $1.98M | 0.1% | $2.82 | -55.5% | COM | 374163103 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 75,000 | $1.725M | 0.1% | $32.88 | 0.0% | COM | 90400D108 |
| LENZ | LENZ THERAPEUTICS INC | 100,000 | $1.6M | 0.1% | — | — | Put | 52635N103 |
| KZR | KEZAR LIFE SCIENCES INC | 229,076 | $1.441M | 0.1% | $5.83 | 0.0% | COM NEW | 49372L209 |
| CMPS | COMPASS PATHWAYS PLC | 200,000 | $1.38M | 0.1% | $5.73 | — | SPONSORED ADS | 20451W101 |
| QURE | UNIQURE NV | 50,000 | $1.196M | 0.1% | $16.30 | +136.8% | SHS | N90064101 |
| — | COGENT BIOSCIENCES INC | 1,000,000 | $1.176M | 0.1% | $1.18 | — | NOTE 1.625%11/1 | 19240QAA0 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 300,000 | $825K | 0.0% | $7.43 | -61.6% | COM NEW | 46489V302 |
| MGNX | MACROGENICS INC | 484,308 | $780K | 0.0% | $1.57 | 0.0% | COM | 556099109 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 50,000 | $652K | 0.0% | $10.07 | +11.9% | CL A ORD SHS | G70077105 |
| FBRX | FORTE BIOSCIENCES INC | 22,400 | $611K | 0.0% | $17.53 | 0.0% | Call | 34962G208 |
| XFOR | X4 PHARMACEUTICALS INC | 145,000 | $580K | 0.0% | $3.63 | 0.0% | COM NEW | 98420X202 |
| QTTB | Q32 BIO INC | 27,777 | $92,220 | 0.0% | $13.78 | -79.5% | COM | 746964105 |
| ADGM | ADAGIO MED HLDGS INC | 80,000 | $83,200 | 0.0% | $4.76 | -75.1% | COM | 00534B100 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 75,000 | $1,823 | 0.0% | $0.16 | — | *W EXP 09/02/202 | 77313F114 |